Infected tooth extraction, bone grafting, immediate implant placement and immediate temporary crown insertion in a patient with severe type-B hemophilia

Calvo-Guirado, José Luís; Romanos, Georgios E.; Delgado-Ruíz, Rafael Arcesio

doi:10.1136/bcr-2019-229204

Cited by 10 publications

(14 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These studies generally reveal the success of implant therapy on a single patient. The scientific evidence is scarce and of a low level, as a total of only 6 articles published over the course of 22 years can be found ( 10 , 18 - 22 ), all of these communicating the results of a single clinical case and taking into account that based on the clinical images published, the case of Gornitsky et al . ( 19 ) may be the same as that of Rosen & Gornitsky ( 18 ), with different scientific considerations.…”

Section: Discussionmentioning

confidence: 99%

2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies

Pérez-Fierro¹,

Castellanos-Cosano²,

Hueto-Madrid³

et al. 2020

Med Oral

View full text Add to dashboard Cite

Background Evaluating 2-years implant loss and marginal bone loss in patients with hereditary coagulopathies, comparing with a healthy control group. Material and Methods 37 implants in 13 patients (17 haemophilia A, 20 Von-Willebrand disease) versus 26 implants in 13 healthy patients. Data measured through Lagervall-Jansson index (after surgery, at prosthetic loading, at 2 years). Statistics: Chi-square, Haberman’s, ANOVA, Mann-Whitney-U. Significance p <0.05. Results Haemorrhagic accidents in 2 coagulopathies patients (non-statistical differences). Hereditary coagulopathies patients suffered more hepatitis ( p <0.05), HIV ( p <0.05) and less previous periodontitis ( p <0.01). Non-statistical differences in marginal bone loss among groups. 2 implants were lost in the hereditary coagulopathies and none in the control group (non-statistical differences). Hereditary coagulopathies patients had longer ( p <0.001), and narrower implants ( p <0.05) placed. 43.2% external prosthetic connection in hereditary coagulopathies patients ( p <0.001); change of prosthetic platform more frequent in control group ( p <0.05). 2 implants lost: external connection ( p <0.05). Survival rate 96.8% (hereditary coagulopathies 94.6%, control group 100%). Conclusions Implant and marginal bone loss at 2 years is similar in patients with hereditary coagulopathies and control group. Precautions should be taken on the treatment for hereditary coagulopathies patients, through prior haematological protocol. Implant loss only occurred in in a patient with Von-Willebrand´s disease. Key words: Dental implants, inherited coagulation disorders, haemophilia A/B, Von Willebrand disease, marginal bone loss.

show abstract

Section: Discussionmentioning

confidence: 99%

2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies

Pérez-Fierro¹,

Castellanos-Cosano²,

Hueto-Madrid³

et al. 2020

Med Oral

View full text Add to dashboard Cite

show abstract

“…Hemophilia is due to an alteration in one of the genes that determine how the body produces clotting factor VIII or IX. It occurs in 1 in 10,000 male births [14] .…”

Section: Etiologymentioning

confidence: 99%

“…The main task is to take a correct clinical history and from this data to be able to make an appropriate treatment plan together with the patient's treating physician [21] . Preventive and local measures should be assessed, together with the specific treatment for each hemostasis disorder [14] . It is of utmost importance to involve the patient in their treatment, explaining that with proper dental care and prophylactic measures, the dentist's intervention will be minimal, reducing the risk of possible bleeding complications [12] .…”

Section: Dental Managementmentioning

confidence: 99%

Untitled

2022

Int. J. Appl. Dent. Sci.

View full text Add to dashboard Cite

Introduction: Hemophilia is an is an X-linked recessive inherited disorder. It belongs to the group of hereditary disorders caused by the deficiency of one or more coagulation factors. Objective:To analyze the literature on the considerations in the dental office in the management of the hemophiliac patient, particularly the etiology, clinical characteristics, diagnosis, treatment and dental management. Methodology: In order to carry out this literature review, an electronic search was necessary using PUBMED and Google Scholar with the words "Hemophilia AND dentistry" "etiology, clinical and dental characteristics, diagnosis and treatment" and "coagulation factors". Results: Hemophilia is due to an alteration in one of the genes that determine the way in which the organism produces coagulation factor VIII or IX. It occurs in 1 in 10,000 male births. It manifests as excessive bleeding in the joints, pain and edema, ecchymosis, urinary tract and digestive tract bleeding. It results in prolonged bleeding from wounds, dental extractions and surgery. The diagnosis of hemophilia is made by taking a blood sample and measuring the degree of factor activity. The main treatment for severe hemophilia is to receive specific clotting factor replacement. During the consultation, a detailed medical history should be taken and comprehensive clinical examinations should be ordered appropriately. The patient should provide the following information: type and severity of his hemophilia, medication ingest, whether he requires pre-treatment with factor concentrate, or an antifibrinolytic agent. Conclusion: Hemophilia is an X-linked recessive inherited disorder. It belongs to the group of inherited disorders caused by deficiency of one or more clotting factors. Practice guidelines are needed to improve the diagnostic process, improve the quality of dental care.

show abstract

“…Kevés információ áll rendelkezésre az implantátumok alkalmazásáról örökletes vérzési rendellenességekben szenvedő betegek esetében. Az irodalomban csak pár esetbemutatást publikáltak implantátum(ok) behelyezéséről haemophiliás páciensek vonatkozásában [23][24][25][26]. Indokolt figyelembe venni, hogy az implantátumok rutinszerű behelyezése nem jelent nagyobb kockázatot, mint a bölcsességfogak eltávolítása.…”

Section: Implantátumok Behelyezéseunclassified

Haemophiliás betegek fogorvosi ellátása

Sipos

2022

View full text Add to dashboard Cite

Az A- és B-típusú haemophilia az egyik leggyakrabban előforduló örökletes vérzési rendellenesség. A veleszületett vérzékenységben szenvedők azonban a népesség kis létszámú csoportját képezik. A betegek kezelése ezért kihívást jelenthet a fogorvosok számára, mivel sokuknak nincs tapasztalata haemophiliás páciensekkel. Ennek következményeként a betegek fogászati ellátása gyakran háttérbe szorul. A vérzékeny páciensek valóban fokozott rizikócsoportba tartoznak a fogorvosi ellátás területén, azonban a legtöbb rutin-, nem sebészeti beavatkozás elvégezhető általános fogászati praxisban is hematológussal történt konzultációt követően, a szakmai protokoll betartása mellett. Átfogó magyar nyelvű ajánlást a veleszületett vérzékeny betegek fogorvosi ellátásának lehetőségeiről nem publikáltak. A közlemény célja, hogy áttekintse és összefoglalja a fogorvosi ellátás irodalmát a haemophiliás betegeket érintően minden fogászati szakterület vonatkozásában. Az irodalmi áttekintés hasznos összefoglalóként szolgálhat a fogorvosok számára, melynek segítségével magabiztosabban kezelhetik pácienseiket, megteremtve a feltételeket a haemophiliás betegek fogászati ellátásának területén tapasztalt nehézségek leküzdéséhez. A közlemény a haemophiliás betegek gondozásában részt vevő szakemberek számára is értékes összefoglalóként szolgálhat a fogorvosi beavatkozásokról és a haemophiliás betegek fogorvosi ellátásának lehetőségeiről. Orv Hetil. 2022; 163(24): 943–951.

show abstract

Infected tooth extraction, bone grafting, immediate implant placement and immediate temporary crown insertion in a patient with severe type-B hemophilia

Cited by 10 publications

References 34 publications

2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies

2-years retrospective observational case-control study on survival and marginal bone loss of implants in patients with hereditary coagulopathies

Untitled

Haemophiliás betegek fogorvosi ellátása

Contact Info

Product

Resources

About